You just read:

Clinical Data Shows Surefire Technology Provides 80% Complete Response Rate for Bridge-to-Transplant Primary Liver Cancer Treatment versus 52% for Standard Microcatheter

News provided by

Surefire Medical, Inc.

Jun 08, 2017, 06:00 ET